Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Synergistic activation of regulatory elements by rel proteins and a steroid receptor

a technology of steroid receptor and receptor, which is applied in the direction of drug compositions, peptide sources, instruments, etc., can solve the problems of hampered development of compounds that exclusively target one set of tissues or organs (e.g. brain for psychiatric illnesses)

Inactive Publication Date: 2008-01-17
NV ORGANON
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Also for these steroid receptors the development of compounds that exclusively target one set of tissues or organs (e.g. brain for psychiatric illnesses) has been hampered by the wide tissue distribution of most types of steroid receptors.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Synergistic activation of regulatory elements by rel proteins and a steroid receptor
  • Synergistic activation of regulatory elements by rel proteins and a steroid receptor
  • Synergistic activation of regulatory elements by rel proteins and a steroid receptor

Examples

Experimental program
Comparison scheme
Effect test

example 1

Materials and Methods Used

[0053] Special Reagents. 17β-estradiol was obtained from Sigma Chemical Co (St Louis, Mo.). 4-hydroxytamoxifen and ICI 164384 were kind gifts from Dr. A. Wakeling, Zeneca Pharmaceuticals, UK.

[0054] Cell Culture. Monkey COS-1 cells and human 293 embryonal kidney cells were obtained from American Type Culture Collection (ATCC; Rockville, MD) and were cultured in a 1:1 mixture of DMEM and Ham's F-12 medium (DF; Life Technologies Inc.), buffered with bicarbonate and supplemented with 7.5% FCS. Dextran-coated charcoal(DCC)-FCS was prepared by treatment of FCS with dextran-coated charcoal to remove steroids, as described previously (25).

[0055] Plasmids. −901 luc was created by partial digestion of −1588luc, a kind gift from Dr. O. Meijer (Leiden, the Netherlands), with Styl, filling-in and ligation into pGL3 digested with SmaI, redigestion with HindIII and religation; −81luc was created by digestion of −1588luc with StyI, filling-in and digestion with BglII an...

example 2

Synergistic Activation of the 5-HT1A Receptor Promoter by NF-κB and ER

[0057] To determine the effect of estrogens on 5-HT1A receptor promoter activity, we transiently transfected COS-1 cells with a reporter construct containing the 5-HT1A receptor promoter together with an expression vector encoding ERα or ERβ. As shown in FIG. 1A, cotransfection of ERα or ERβ and treatment of the cells with 17β-estradiol (E2) hardly had an effect on 5-HT1A promoter activity. However, besides direct regulation, ER target genes can also be regulated indirectly through interaction of ER with other transcription factors. Putative NF-κB binding sites were shown to be present in the −901luc 5-HT1A receptor promoter construct (see FIG. 2A) and transfection of this reporter construct with expression vectors encoding the p50 and p65 subunit of NF-κB resulted in an 10-fold induction of the reporter. Interestingly, cotransfection of ERα in combination with NF-κB now resulted in an enormous induction of promo...

example 3

Involvement of NF-κB Elements in 5-HT1A Receptor Promoter Regulation by NF-κB and ER

[0059] To localize the effect of ER on the 5-HT1A receptor promoter, several promoter deletion constructs were used (FIG. 2A). Mutation of both NF-κB elements (−901 365 / 64Mluc) completely abolished the effect of NF-κB on the 5-HT1A receptor promoter (FIG. 2B). However, ERα, only in combination with NF-κB, was still able to induce promoter activity as efficient as on the wild type promoter (−901 luc). Likewise, the promoter construct −81luc could not be induced by NF-κB, although it still contained one NF-κB element. However, also on this promoter construct, the effect of ERα with NF-κB was maintained. When the single NF-κB element present in the −81luc construct was mutated (−81 64Mluc), the ERα effect was almost completely abolished. Thus, synergistic activation of the 5-HT1A receptor promoter involves NF-κB binding sites, although activation of the promoter by NF-κB itself appears not to be requir...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
modular structureaaaaaaaaaa
neuronal plasticityaaaaaaaaaa
Topcount liquid scintillation counteraaaaaaaaaa
Login to View More

Abstract

Interaction of Rel proteins and steroid receptors is known to result in repression of target genes. Here we describe the discovery of a new mechanism in which Rel proteins and steroid receptors act synergistically to activate a regulatory element. This mechanism is shown to influence the expression of the brain-specific 5HT1A receptor wherein the estrogen receptor acts synergistically with the Nuclear Factor kappa B to enhance the activity of the promoter for the 5HT1A receptor gene. In addition, synergistic effects of Rel proteins with the mineralocorticoid receptor were observed, showing that synergism with Rel proteins may be expected for other steroid receptors as well. The synergism between Rel proteins and estrogen receptor or mineralocorticoid receptor provides a tool for the development of compounds that interact with the estrogen or mineralocorticoid receptor in such a way that only the synergistic effect is modulated whereas other effects are left intact. Such compounds would be invaluable for the development of medicaments for the treatment of diseases of the central nervous or cardiovascular system and other disorders in which Rel proteins play a role.

Description

RELATED APPLICATION [0001] This application is a division of U.S. application Ser. No. 10 / 220,709 filed Nov. 18, 2002 which claims priority based on International Patent Application No. PCT / EP2001 / 02585, filed on Mar. 6, 2001, and European Patent Application No. 00200815.9, filed Mar. 8, 2000.FIELD OF THE INVENTION [0002] The invention relates to a method for the identification of compounds capable of modulating a newly discovered mechanism whereby a steroid receptor and a Rel protein act synergistically to activate a regulatory element. The invention also relates to a cell transfected with nucleic acid and the use of that cell in an assay for the identification of compounds that modulate the level of gene expression under the control of the regulatory element as well as the medical use of compounds identified in such an assay. BACKGROUND OF THE INVENTION [0003] Members of the Nuclear Factor-κB (NF-κB) / Rel family of transcription activator proteins are tightly associated with their ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): C12Q1/68C12N5/06A61K45/00G01N33/50A61P9/00A61P25/00C07K14/47C07K14/705C07K14/72C12N5/10C12N15/09C12Q1/02G01N33/15G01N33/74
CPCC07K14/4702G01N33/743C07K14/721A61P25/00A61P9/00
Inventor BOERSMA, CHRISTINEVAN DER SAAG, PAULUSWISSINK, SACHAVAN DER BURG, BART
Owner NV ORGANON
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com